![]() ![]() GSK stock trades 34% below our fair value estimate of $54 today.Ĭampbell Soup stock trades at a 34% discount to its fair value of $61. Conover thinks the market underappreciates the global growth potential for the company’s shingles and RSV vaccines. GSK reported solid earnings in the most recent quarter. One of the largest pharmaceutical and vaccine companies, GSK’s innovative new product lineup and expansive list of patent-protected drugs earn a wide moat rating, says Morningstar’s Conover. Imperial Brands stock trades 34% below our fair value estimate of $36 per share, which we recently raised from $34 to account for a stronger U.S. Gorham nevertheless says Imperial Brands should remain a highly profitable and cash-generative business. As a result, the company is likely to be more exposed to cigarettes in the future relative to its peers, who are investing for growth and moving away from the secular decline in cigarettes. Morningstar director Philip Gorham refers to this Big Tobacco name as a “fast follower” rather than a leader in most markets. Tobacco company Imperial Brands rejoined our list of best companies to buy now. We think Zimmer Biomet stock is worth $175 per share. We were surprised by the CEO change announcement earlier this year, but considering how well the current business strategy is working, we don’t expect new management will bring wholesale changes, she adds. We award the company a wide moat rating thanks in part to the high switching costs that orthopedic surgeons would face if they transitioned to another company’s instrumentation, says Morningstar senior analyst Debbie Wang. Zimmer manufactures orthopedic reconstructive implants. Zimmer Biomet stock is trading 35% below our fair value estimate. The Best Companies to Own: 2023 Edition Zimmer Biomet We expect the company to benefit from a consumer shift in both developed and emerging markets toward higher-end beauty brands. Given its brand equity and cost advantages, we assign the company a wide moat rating, explains Morningstar analyst Dan Su. With brands that include its namesake, Clinique, and Aveda, Estee Lauder is a leading provider of premium beauty products that has a strong presence across both brick-and-mortar and digital channels. We expect the firm’s fiscal 2024 sales to be flat owing to lower demand for high-margin skincare products amid macro headwinds.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |